Aptose biosciences Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Aptose biosciences Contact Number

Executive Headquarters. 12770 High Bluff Drive, Suite 120 San Diego, CA 92130, USA Tel: 858.926.2730

Contact US: https://www.aptose.com/contact

Board

63 People Used

See More ››

Contacts :: Aptose Biosciences Inc. (APTO)

Aptose Biosciences Inc. Home; About. Overview; Management Team; Board of Directors; Scientific Advisory Board

View Contact ››

Leukemia

26 People Used

See More ››

Aptose Biosciences Inc. (APTO)

Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical need in chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other hematologic malignancies. Who We Are.

View Contact ››

Company

56 People Used

See More ››

Company Information :: Aptose Biosciences Inc. (APTO)

Company Contact Aptose Biosciences Inc. 12770 High Bluff Drive Suite 120 San Diego, CA 92130 USA T: 858.926.2730

View Contact ››

Ontario

88 People Used

See More ››

Aptose Biosciences Inc. Profile

Aptose Biosciences Inc. Mailing Address: 251 Consumers Road Suite 1105 Toronto, Ontario M2J 4R3: Head Office Address: 251 Consumers Road Suite 1105 Toronto, Ontario M2J 4R3: Contact Name: Gregory K. Chow: Principal Regulator: Ontario: Business e-mail address: [email protected]aptose.com: Short Form Prospectus Issuer: Yes: Telephone Number: 650 718-5028

View Contact ››

Phone

64 People Used

See More ››

Aptose Biosciences

Phone Number 416-798-1200 Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles.

View Contact ››

Number)

52 People Used

See More ››

APTO

Participants can access the conference call by dialing 1-844-882-7834 (North American toll-free number) and 1-574-990-9707 (international/toll number) and using conference ID # 2788133. For further information, please contact: Aptose Biosciences Inc. Susan Pietropaolo

View Contact ››

Lymphocytic

47 People Used

See More ››

Product Pipeline :: Aptose Biosciences Inc. (APTO)

Oral, Mutation-Agnostic FLT3/BTK Inhibitor. CG-806 is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. View Candidate.

View Contact ››

Aptose

93 People Used

See More ››

Working at Aptose Biosciences Glassdoor

Glassdoor gives you an inside look at what it''s like to work at Aptose Biosciences, including salaries, reviews, office photos, and more. This is the Aptose Biosciences company profile. All content is posted anonymously by employees working at Aptose Biosciences.

View Contact ››

Aptose

109 People Used

See More ››

Aptose Biosciences Inc. (APTO) upgraded Issued by Wall

Aptose Biosciences Inc. (NASDAQ:APTO) went down by -10.38% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price has collected -9.89% of loss in the last five trading sessions. Press Release reported on 05/04/21 that Aptose Reports Results for the First Quarter 2021. Get the hottest stocks to trade every day before the market opens 100% free.

View Contact ››

Please leave your comments here:

Popular Brands

Amazon
Asml
Abbvie
Apple
Att
Acc
Amd
Abb
Aak
Agco